Home/Filings/4/0001209191-22-003195
4//SEC Filing

Sofinnova Partners SAS 4

Accession 0001209191-22-003195

CIK 0001868734other

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 4:36 PM ET

Size

13.6 KB

Accession

0001209191-22-003195

Insider Transaction Report

Form 4
Period: 2022-01-11
Transactions
  • Conversion

    Series B Preferred Stock

    2022-01-113,150,0000 total(indirect: By Sofinnova Capital IX)
    Common Stock (926,470 underlying)
  • Conversion

    Series A Preferred Stock

    2022-01-119,999,9990 total(indirect: By Sofinnova Capital IX)
    Common Stock (2,941,176 underlying)
  • Conversion

    Common Stock

    2022-01-11+3,867,6463,867,646 total(indirect: By Sofinnova Capital IX)
  • Purchase

    Common Stock

    2022-01-11$16.00/sh+220,000$3,520,0004,087,646 total(indirect: By Sofinnova Capital IX)
Transactions
  • Conversion

    Common Stock

    2022-01-11+3,867,6463,867,646 total(indirect: By Sofinnova Capital IX)
  • Purchase

    Common Stock

    2022-01-11$16.00/sh+220,000$3,520,0004,087,646 total(indirect: By Sofinnova Capital IX)
  • Conversion

    Series A Preferred Stock

    2022-01-119,999,9990 total(indirect: By Sofinnova Capital IX)
    Common Stock (2,941,176 underlying)
  • Conversion

    Series B Preferred Stock

    2022-01-113,150,0000 total(indirect: By Sofinnova Capital IX)
    Common Stock (926,470 underlying)
Footnotes (2)
  • [F1]Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date.
  • [F2]The shares are directly held by Sofinnova Capital IX ("SC IX"). Sofinnova Partners SAS ("Sofinnova Partners") is the management company of SC IX and may be deemed to share voting and investment power over the shares held by SC IX. Sofinnova Partners disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.

Issuer

CinCor Pharma, Inc.

CIK 0001868734

Entity typeother
IncorporatedFrance

Related Parties

1
  • filerCIK 0001574139

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:36 PM ET
Size
13.6 KB